15 Advocates to Watch in 2015

Mark S. King of MyFabulousDisease.com published a piece in The Body listing 15 HIV advocates worth watching in 2015. The list includes AVAC’s 2014 Fellow Yvette Raphael of South Africa.

In the city of Midrand Gauteng in South Africa, Yvette Raphael stays busy running her catering company. “I do it because I love making people happy and every meal is prepared with love,” she says. Love is also something Yvette shares generously with her extended family, including three young girls living with HIV for whom she serves as guardian and mentor.

None of these responsibilities, though, have kept her from becoming an emerging voice for women living with the virus.

Diagnosed with HIV in 2000, Yvette contributes to a number of national and global efforts, including working in support of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Campaign to End AIDS, and serving as a 2014 AIDS Vaccine Advocacy Coalition (AVAC) Fellow associated with Johns Hopkins University. Her influence is growing faster than a baking souffle.

“Yvette is a rare breath of fresh activism in a time in the AIDS movement that needs more advocacy and policy change, not less,” said Dazon Dixon Diallo, founder of Sisterlove and one of the preeminent global voices for HIV among women. “She comes to the movement with a fierce brilliance and a fearless voice for women, youth and the African LGBTQ community. Yvette is a young, single mother who works hard to defend and protect the human rights of all, especially young girls. She rocks on all fronts!”

Click here to read about the other 14 advocates!

Black Gay and Bi Men Battle the Escalation of HIV

In an article for HIV Plus Magazine, Charles Stephens, founder of the Counter Narrative Project and a member of AVAC’s PxROAR advocacy cadre, talks about the importance of gay black men remembering “our legacy” related to HIV and AIDS and stigma and discrimination.

“The black gay male experience is profoundly alienating,” says Charles Stephens in front of a packed audience…

“As black gay men, more often than not, we are denied a history, denied a culture, and often represented in the most narrow and simplistic forms. We are robbed of our lovely complexity far too often in mainstream culture, and that is in itself a form of violence. To strip someone of their complexity is to strip them of their humanity.”

The article also talks about the black gay male experience in the US as it relates to the broader LGBT agenda of marriage equality. Read more.

Happy New Year!

AVAC would like to wish our advocates and friends from across the globe a Happy New Year! The Weekly NewsDigest will return to its regularly scheduled delivery this Friday.

Here’s to much success this New Year!

Will 2015 be the year for PrEP and women?

In the run-up to the busy holiday season here in New York, a number of great pieces focusing on women and PrEP came out, including new data on PrEP knowledge and attitudes, a video depicting one of our favorite stories of early PrEP use in the Bay Area, another great webinar from the US Women and PrEP Working Group, and a piece from a freelance journalist who took on the question of why so many women are still being infected with HIV when there’s a pill to prevent it. Check it all out below!

In late December 2014, data on knowledge, attitudes and likelihood of PrEP use in US women was published in the journal AIDS Patient Care and STDs. The study was conducted by AIDS United and included focus group discussions with 150+ women from across the United States. Key findings include women’s interest in PrEP as an additional prevention tool and identification of potential barriers that to be addressed to provide access for women in the US. Download the article here.

This Pill Prevents HIV, So Why Are So Many Women Still Being Infected?” is a piece that features commentary from a range of advocates and PrEP users, including the story of sex-positive advocate Julie Lynn and her decision to begin taking PrEP. The article reminds readers of the need to ensure the conversation on—and implementation of—PrEP in women includes all women at risk, not just those who are part of serodifferent couples and want to use PrEP for safer conception.

The idea of “PrEP-ception” has been pioneered by women’s health and HIV advocates and has been advanced largely due to early efforts from those at the Bay Area Perinatal AIDS Center (BAPAC) in San Francisco, California. One of the first couples to use PrEP to safely conceive worked with BAPAC. The story of “Poppy” and “Ted” (pseudonyms used to protect their privacy) is one of an HIV-serodifferent couple—Poppy is HIV-negative and Ted is HIV-negative—who wanted to get pregnant without the expense of sperm washing, one of the options used by HIV-negative women looking to get pregnant by their HIV-positive partners. Poppy went on PrEP and had condomless sex with her husband for the first time, which happily led to the birth of her adorable—and HIV-negative—daughter Macey. Check out the Fusion TV segment on their wonderful story.

Circling back to the idea of risk and how to do a better job at ensuring all women at risk know about and have access to PrEP, if desired as an HIV prevention option, the US Women & PrEP Working Group recently hosted a webinar: How Do Women Think about HIV Risk? The conversation around women’s perception of HIV risk and how this perception impacts care providers and PrEP as a prevention option is critical. Sign in here to access slides from the webinar and the recording.

Resources, articles and discussions on PrEP are on the rise, and we’ve highlighted just a few of them here. New usage data show that PrEP use in the US among some populations and communities is going up and one has to imagine that it is partly due to increased, accurate coverage and awareness. But, as described in the article above, the conversation around PrEP and women has not experienced the same amplification effect as that of gay men and PrEP over the last year. More women (and men) can benefit from PrEP than are currently accessing it. We—providers, advocates, public health agencies and anyone who talks to a woman about her health—have to do better.

Will 2015 be the year for PrEP and women? And not just in the US but globally? We sure hope so.

Want more information on the US Women and PrEP working group and its activities? Check it out here. Interested in working with us on this issue in 2015? Drop us a line.

Overcoming HIV Obstacles in 2015

AVAC’s Executive Director, Mitchell Warren, recently spoke with the Voice of America. This article first appeared here.

The head of a prominent HIV/AIDS advocacy organization says 2015 will be a year of great opportunities and great challenges. The epidemic is nearly 35 years old and more than 30 million people are estimated to be living with HIV.

Mitchell Warren said one challenge of the New Year will be to translate recent scientific advances into practice. Warren is executive director of AVAC, which, he said, “aims to accelerate the ethical development and global delivery of HIV prevention tools as part of a comprehensive response.”

“This is a year that will define the AIDS response. We’re now over 34 years into the epidemic. And it is truly a point at which we will know if we are on the right track to ever ending this epidemic, or if we continue to muddle through year by year hoping we do the right things, but not knowing for sure,” he said.

Promising prevention option

Early in 2015, results should be announced regarding a promising HIV prevention option – an effective microbicide.

“As you may recall, back in 2010, we had the initial proof of concept of the CAPRISA trial that showed the tenofovir gel provided some partial protection for women in South Africa,” he said.

Tenofovir is an antiretroviral widely used to subdue the virus within the body. But it’s also been shown to be effective in preventing infections.

Since 2010, a study has been underway to confirm and expand on the CAPRISA findings. It’s called FACTS001 and is also taking place in South Africa. The study is funded by the U.S. and South African governments and the Gates Foundation.

Warren said FACTS001 could confirm whether tenofovir gel, used before and after sex, can prevent HIV infection.

“The results were expected in the first quarter of the year. If that’s a positive result and if it confirms the CAPRISA finding, we would then be looking at how do you take that product forward — outside of clinical trial – into practice? So a very exciting first quarter I think just because of that trial result.”

At the end of 2015 and in early 2016, the results of two other microbicide studies are expected to be released. One will look at the effectiveness of a vaginal ring filled with an antiretroviral drug.

Also, in South Africa, an AIDS vaccine trial gets underway this year. It’s a follow-up to the 2009 Thailand vaccine trial that showed protection against HIV was possible. The results from the South Africa trial and related studies, however, will not be available for several years.

Improving detection

Meanwhile, greater use of antiretrovirals as a preventive measure is expected. It’s called PrEP, or pre-exposure prophylaxis. But the AVAC executive director said the predominant use will remain as treatment for those infected.

“2014 ended with the calls by the United Nations AIDS program, UNAIDS, to really set a new target about treatment. The UNAIDS new target is this 90/90/90, trying to make sure that 90 percent of people who are infected know their status. That 90 percent of them get onto treatment and that 90 percent of those on treatment are, what we call, virologically suppressed. And if they’re virologically suppressed it means they are very unlikely to transmit HIV,” he said.

He said an “ambitious, but feasible” goal would be to have 15 million people on HIV treatment by the end of 2015.

“That would be a terrific step in the right direction, but of course there are over 30 million people infected with HIV. So we have a very long way to go to really see treatment scale up to the degree that we need it to. But it is on the right trajectory. Drug pricing is coming down because you have much higher volumes.”

However, he added that there are antiretroviral supply problems at some clinics in developing countries.

“For all of the excitement around prevention, around treatment, it really becomes a resource question. Because this success in the AIDS response does not come cheap and it certainly does not come free. And the question really becomes are we as a global community going to continue to scale up our investments in the things that we know can work? Because all the talk of ending the epidemic is predicated on good science and on real resources. And we’re beginning to see those resources eroding,” he said.

Warren does not foresee an end to the HIV/AIDS epidemic for at least 10 years. One of the obstacles is ongoing stigma and discrimination. He said unless that problem is solved, no vaccine or antiretroviral will be effective in the long-term. He said that “there is no medical response that can address people’s perceptions of others.”

Gay Nigerian Actor Puts His Sexuality in the Spotlight

Below is a National Public Radio interview with activist Adebisi “Bisi” Alimi speaking (from a safe distance) to the double hardship of being gay and living with HIV in Nigeria. Bisi currently resides in London where he is a lead advocate on gay rights within the LGBT migrant African community. He is an original member of AVAC’s PxROAR Europe program, bringing HIV biomedical prevention advocacy and education to affected communities such as the African MSM diaspora. You can access his recent article Prepping Gay Men for PrEP on Project Syndicate here.

Adebisi Alimi is the first person ever to come out as gay on Nigerian television. But that wasn’t what the 29-year-old wanted to be known for back in 2004.

Alimi’s acting career was just starting to take off when his sexuality stole the spotlight. The student newspaper at University of Lagos, where he was studying theater, threatened to publish a photo of him with his then-boyfriend. So Alimi beat them to the punch. He went on “New Dawn with Funmi,” one of the most popular talk shows in Nigeria, and challenged a long-held belief that homosexuality was brought to Africa by white colonizers. That was also the year Alimi was diagnosed with HIV.

Suddenly, his home country no longer saw him as a rising star. Alimi lost his roles on TV and on stage, many of his friends shunned him and the police even arrested him on unexplained charges. In 2007, things got worse. He was detained at the airport on his way back from the United Kingdom, where he gave an interview to BBC Network Africa, and was released two days later. Then a group of men entered his home and attempted to kill him. Alimi fled to the UK and hasn’t been back to Nigeria since.

But Alimi says, “My story is not a story of a victim; it’s a human story.” Without it, he says, he wouldn’t be the outspoken activist he is today.

Now 40, Alimi shares his story when he speaks out for the rights of gay black and African men. He’s the founder of Bisi Consultancy, an organization that develops social policy recommendations based on HIV research on the lesbian, gay, bisexual and transgender community. For his birthday on Jan. 17, Alimi has also started a campaign called 40four40 to raise 40,000 pounds — or about $62,000 USD — for four LGBT charities.

Previously, he founded the Independent Project For Equal Rights-Nigeria, a nonprofit for LGBT youth, and helped set up the UK’s first international LGBT organization, Kaleidoscope Diversity Trust.

And while he’s no longer living in Nigeria, Alimi is deeply affected by the country’s anti-gay law passed in January. The law mandates a 14-year prison sentence for those who marry someone of the same sex and 10 years for anyone who, directly or indirectly, supports LGBT organizations.

Alimi was in Washington, DC last month for the 2015 Aspen New Voices Fellowship. Asked about his thoughts on the law, he says that, in a way, “I’m happy about it.”

Why are you happy about Nigeria’s harsh anti-gay law?

I see the law as a catalyst for change for good in Nigeria. You don’t understand what it is like to fight a beast that you cannot see. Before the signing of that law, between 95 and 98 percent of Nigerians were in support of it. The latest poll says 88 percent of Nigerians now support the law. That’s a 10 percent drop. Some people who are not LGBT are now saying, “Did we just support a law that criminalizes people… for falling in love?” [When] you see that your uncle or cousin is gay, it kind of changes the conversation.

Speaking of family, how does your family feel about your identity?

I’m in a relationship that I can’t talk to my parents about — it’s like a big elephant in the room. But [the fact that] they want to accept me [as gay] is a form of support.

I was diagnosed [with HIV] in 2004, and I’ve never discussed it with my parents. This is my personal life, and I don’t want them to get involved with it. Many times when I struggle with the challenges of being gay and being [HIV] positive, even living in diaspora and so many other things, I just really want to have somebody I can cry to who has blood lineage but I just said no.

So who is in your support network?

Mostly close friends. Many times it’s people I don’t know. I remember one incident when I was at my university. I was going back to my room at night and I was stopped by two guys. They were making very derogatory statements and becoming really aggressive. There was a [student] coming. So I raised my voice: “What did I do to you, why are you guys so frustrated with me?” [The student] stopped and said, “What’s going on?” I told her these guys were attacking me, and they said, “Oh he’s gay, he’s a faggot.” She just looked at them and said, “What if he’s a faggot? What’s your problem?” She stood up to them. These are the unsung heroes of my existence because anything could have happened that night.

Back in 2007, a group of guys tried to kill you and that’s when you fled the country. But did you ever want to leave Nigeria before then?

I was lucky enough to go through a 2-hour ordeal of being beaten and almost being shot in the head and escaping. If those guys are still alive, they might have read one or two of my interviews. I wonder how they feel that they almost killed me. But I felt that leaving was never a choice until my mother said, “Do you still have reason [to stay]? I think you should leave.”

How did you react when when you were diagnosed with HIV?

By 2001 I started working in HIV prevention because I lost my best friend [to the disease]. So I was kind of aware. That was why my diagnosis was a shock to me. I broke down and started crying and thought like this is the end of my life because I have seen my friends die. It’s such a big thing that even within the gay community, if you’re positive, that’s the end of it. Nobody wants to talk to you or date you, but you become the story everyone wants to talk about. So I didn’t tell anybody. I carried it for three years before leaving Nigeria. I didn’t start medication until 2009.

If you had known about the treatments and support for HIV then, would you have reacted differently?

No, because then I might still be in Nigeria. And I still wouldn’t want to talk about it because it would still be a death sentence. Treatment is a big challenge and people [in Nigeria] still don’t have access to it. And the support system is still not there because of the stigma against gay men — it’s a belief that [HIV] is a punishment from God. So it’s very difficult to exist with that system.

How would you assess the progress across Africa in providing HIV treatment?

We are still betraying generations when it comes to HIV prevention and treatment. Many people still need access to this treatment and we still have children being born with the virus when we know we can prevent it. We’re lacking political willpower and funding to HIV projects. It has become a political game.

Being an advocate gives you a different kind of stage than acting does. If you had a choice, would you go back in to acting?

I think I studied theater because I was pretty much a drama queen [laughs]. Acting is my biggest passion. The unfortunate thing is that it’s something I would never touch again because it left a big scar in my life. Even when I did try to go back to acting, I kept thinking, “If you keep doing this, you’re going to bring up media interest again.” I have media interest now but it’s very humane. It’s not about who I kissed last night or who I’m hanging out with.

So you’re done with theater?

If there’s anything I want to go back to, it’s acting. I want to be back on stage dancing and acting, but I’m also very scared of it.

Looking Back and Moving Forward

We often refer to AVAC as a translation organization—translating complex scientific concepts to a range of lay audiences and translating complex community perspectives into the scientific process. As we reflect on 2014, it’s clear that this work is as essential and necessary today as it was when AVAC was founded nearly 20 years ago.

From public health programs introducing daily oral pre-exposure prophylaxis (PrEP), to clinical trials of passive immunization with broadly-neutralizing antibodies, biomedical HIV prevention is complex, dynamic and in motion. And in this fast-changing world, it remains our commitment and our daily work to partner with activists and advocates to ensure that we all keep up.

This means keeping up the pressure on normative agencies and donors to be specific, strategic and reality-based in target-setting and implementation. It means sitting down in small groups and large webinars to understand the ramifications of the latest trial results. It means keeping up the call for full funding for HIV research and implementation because we all know that the AIDS crisis isn’t over.

The generous support of our members and donors has been critical to build and mobilize a global network of partners to increase awareness and understanding of the current state—and the future—of HIV prevention research and implementation, and we hope you will continue to support us with your work, wisdom and resources in the coming year.

Next year will be as fast-paced as ever. In the first quarter of 2015, there will be detailed data from two oral PrEP studies in gay men and other MSM in Europe. The FACTS 001 trial of tenofovir gel is also preparing to release data. And several other key HIV prevention trials will be getting underway. All of this will happen in the context of ambitious treatment and prevention targets and diminished funding. With your support, AVAC can be there—to engage, communicate and advocate.

In 2014, your support and collaboration allowed us to:

Please consider making a contribution at www.avac.org/donate. You can also shop online at Amazon via smile.amazon.com and select “AVAC” and a portion of your purchase is donated to us—at no additional cost to you.

We are proud of the work to date—now entering our 20th year as an organization—and we are continually energized and inspired by the opportunities to work with so many remarkable individuals and organizations.

Many thanks in advance for your continued support!

For Women in South Africa, HIV Stigma Still Runs Strong

This article first appeared in the Global Post.

Yvette Raphael left the medical clinic in Midrand, Johannesburg with one thought running through her mind.

She wanted to be dead.

She couldn’t face her baby, she thought. She couldn’t face her sister. She couldn’t face her mother. Her startling HIV diagnosis haunting her every thought, Yvette stepped into the street at the bottom of a hill, right into oncoming traffic.

“At the time, AIDS deaths were described as very painful, very long suffering —everyone would know what’s wrong with you,” Yvette said. “I thought it would take three months for me to be dead.”

“I knew I needed to know, do I have recourse as a person living with HIV?”

In what she now counts as one of the luckiest moments of her life, the taxi coming down the hill slammed on its brakes, stopping right in front of her. The driver took her bag, found her diary with her address in it, and drove her home.

As Yvette, 39, recalls that day 15 years ago when she found out she was HIV positive, she looks healthy and bright like the yellow patterned dress she is wearing. She had come to Cape Town from her home of Johannesburg to take part in the first-ever HIV Research for Prevention Conference, convening researchers, academics and activists to discuss breakthroughs and challenges in the field of HIV prevention.

An HIV diagnosis is no longer a death sentence, thanks to advances in medicine and treatment in the last 30 years. But stigma against HIV/AIDS and fear of discrimination still run strong in South Africa, despite legal protections, as well as drastically improved treatment, prevention techniques and education. Today an estimated 19 percent of South African adults ages 15-49 are living with HIV.

And women, who represent about 60 percent of people living with HIV in South Africa, face a disproportionately large array of consequences, including physical violence and abuse.

“Upon disclosure of women’s HIV positive status,” reads a 2012 study by the AIDS Legal Network on gender violence and HIV, “women’s lives change, due to fear and the continuum of violence and abuse perpetrated against them.”

Although forced or involuntary disclosure of one’s HIV status — along with any discrimination that may result from that disclosure — was made illegal by South Africa’s post-apartheid constitution, experts and advocates say that public knowledge of these laws is limited and the legal system is not equipped to implement them.

Women and HIV

As of 2013, South Africa had the most people living with HIV in the world. Though new infections have been steadily declining in the country since 2000, there are still more than 6 million people living with the virus.

And HIV prevalence is much greater in women than in men, especially in younger populations. United Nations Population Fund (UNFPA) statistics show that for people ages 20-24, HIV prevalence is at 17.4 percent for women and 5.1 percent for men.

Not only are women disproportionately affected by HIV, but they are also more likely to know their status. More women get tested, said Rukia Cornelius, community education and mobilization manager at the NGO Sonke Gender Justice, based in Johannesburg and Cape Town, because unlike men, women need antenatal care.

And often, she said, clinics give women HIV tests when they come in for prenatal visits.

The way hospitals and clinics are set up also are not always conducive to protecting privacy, said Alexandra Muller, researcher at the School of Public Health and Family Medicine at the University of Cape Town.

“People who provide services in the public system, at the community level, are community members,” said Muller. “This is an important dynamic when we think about stigma and disclosure.”

Doctors and nurses can see 60 to 80 patients per day in an overcrowded facility with shared consultation rooms, Muller said.

“There’s not a lot of consideration for how is a clinic set up,” added Cornelius, so that “a health care worker who has done your test and knows your status doesn’t shout across the room to the other health care worker, ‘okay, this one’s HIV-positive, that file goes over there.’”

Once HIV-positive women disclose their status, willingly or not,they are disproportionately affected by stigma because of the direct link between HIV and gender violence.

The 2012 “Gender Violence & HIV” report links the two, explaining that high levels of violence against women lead to a higher risk of HIV for those women, and a woman’s positive HIV status leads to a higher risk of violence and rights violations.

“Women’s experiences of living with HIV are a clear illustration of multiple forms of abuse and violence in all spheres of their lives, perpetrated by partners, families, friends, communities and service providers alike,” the study said.

“It’s about, generally, how society relates to issues of when, and how, we talk about sex and sexuality and power and gender norms,” said Cornelius. “And often, all of those things play out in overt ways that leaves women vulnerable and compromised.”

* * *

Yvette was diagnosed in 2000, and she didn’t begin talking about her HIV status until a year later. She started by joining secret chat rooms because no one in her life knew that she was HIV positive.

Then, her boss at SASSETA — an organization that promotes training and development for South Africans in the safety and security sector — asked her to arrange for a speaker for a World AIDS Day event they were planning.

With 80 colleagues in the room, she said, she told them her secret. “I told them I’m HIV positive. They don’t need a speaker, because I’m going to tell them about my life.”

When Yvette disclosed her status at work, she had not yet told her family. But she had a cousin who worked with her and told her relatives at a family meeting before Yvette had a chance to do so herself.

“I walk into this family house, and there’s close to 20 people there, all who know me, and everyone’s talking behind my back. Everything that I wanted to avoid,” she said.

“Everybody was whispering, saying stuff that I did not understand,” she said. “The fact that she went and disclosed my status to other people did more harm than good.”

It was because of her positive HIV status that Yvette picked up the South African constitution for the first time.

“I knew I needed to have my human rights in check. I knew I needed to know, do I have recourse as a person living with HIV,” she said.

South Africa’s constitution is one of the most progressive in the world and ensures the right to privacy and equality. The Promotion of Equality and Prevention of Unfair Discrimination Act (PEPUDA), passed in 2000, gives effect to the equality clause of the constitution by outlawing forced disclosure of HIV status and discrimination based on one’s status, said Katy Hindle, an attorney and the policy development and advocacy research associate at Sonke Gender Justice.

Yvette said she didn’t want to pursue legal recourse against her cousin because it was close family.

“I knew I could report her, I knew I could sue her, I knew I could do anything. It was going to be such a long battle. Was it worth putting the family in that situation? No,” she said.

After three years without speaking to her cousin, Yvette said, she eventually forgave her, realizing that she hadn’t meant harm. Rather, Yvette said, her cousin just had not known what to do with the information she had been given.

Unlike Yvette, most South Africans do not pick up the constitution and do not know that they are protected. A 2013 Foundation for Human Rights Survey found that only 10 percent of those interviewed had read any part of the constitution or had any part read to them, and only 46 percent knew of the constitution’s existence.

Even when women do know that their rights are protected, reporting cases of forced or involuntary disclosure or discrimination based on HIV status can be challenging, and access to court systems can be difficult.

Section 27, a Johannesburg-based public interest law center, has tracked only 12 cases related to HIV, discrimination and confidentiality that have been brought to court since 1993.

“I’ve heard it referred to as ‘magic legalism,’ which is this idea that you enact something, and because it’s progressive and it’s the right kind of legislation, it will suddenly have a ripple effect of positive benefits,” said Hindle. “In practice, that isn’t the case, and that hasn’t been the case in South Africa.”

Police stations are often not set up to allow women to disclose their status to a police officer privately, said Cornelius. And even if a woman does report a rights violation, it takes a lot of time and money to go through with legal action — two things that many women don’t have.

“If a woman’s status if involuntarily disclosed and she decides to take legal action in that regard, she’d have to have a lot of financial resources,” Cornelius said. “If you don’t have the resources? Good luck.”

Access to court systems is further limited by the public’s perceptions of the legal system, which were heavily shaped during apartheid, said Hindle.

During apartheid, “the legislature and the parliament in South Africa would pass laws that weren’t based at all on the will of the majority and weren’t democratic or fair. I think because of that, most people don’t really come to realize courts as a place where you can access or protect your rights,” she said.

Improvements

Stigma related to HIV/AIDS has decreased in South Africa and views have shifted, stated an article published this year by BMC Public Health, which outlines the results of an exploratory survey to measure stigma in the country.

The report points to results from the National HIV and AIDS Household Survey: In 2002, over 80 percent of participants said they would not sleep in the same room as someone who is HIV positive. In 2005, about 47 percent said they were hesitant to marry someone who is HIV positive.

Improvements in treatment and scientific advances are an additional source of decreased stigma, said Hindle.

“A lot of people who are HIV positive … live healthily, they live for much longer, they live comfortably. And all of those things, I think, have positively impacted discrimination and stigma,” she said.

Still, the survey on stigma concludes, “the advances made by scientists in the diagnosis, prevention and treatment have unfortunately not been matched by advances in social acceptance of the disease.”

After disclosing her status, Yvette helped the safety and security sector conceptualize an HIV/AIDS policy, and she was appointed as the HIV/AIDS coordinator for SASSETA. Now a 2014 fellow at AVAC — a nonprofit organization dedicated to global advocacy for HIV prevention — Yvette counts herself as an activist.

Her real motivation is her children, she said. Her daughter is now 15 and her son is 7.

She has used milestones in her daughter’s life as markers — first she vowed to see her through daycare, then to five years old, then to ten. She said her kids are her yardsticks in life.

“When I was diagnosed, I was in a very bad space. I was in a space of almost being suicidal, and getting past that is taking it one step at a time,” Yvette said. “We all need to find that reason why we live, why we are alive.”

Human Rights Day: LGBT activists discuss barriers to rights and HIV services with UN agencies and member states

Last week, The International Gay and Lesbian Human Rights Commission (IGLHRC) brought together more than 50 LGBT activists from around the world in New York City to mark this year’s International Human Rights Day. The delegation included 10 activists from Zambia, Egypt, Cameroon, Nigeria, Zimbabwe and South Africa, as well as other activist from Asia, South America and the Caribbean. The group attended several UN agency meetings and met with member states to raise their voices about the issues most important to them.

AVAC Policy and Program assistant Micheal Ighodaro was part of the delegation and facilitated the HIV/AIDS discussions during the activist planning sessions and was part of the delegation that visited UNICEF, UNDP and UNAIDS.  In these sessions the activists shared their lack of full understanding of the different UNAIDS targets and lack of African LGBT representation during development of these targets. Below is Micheal’s account of more advocacy discussions throughout the day.

Despite gains in controlling the spread of HIV in Africa, the disease has continued to spread at an alarming rate among its LGBT communities. This, the activists say, is becoming even more severe. They report that HIV programs targeting gay men are only available in big cities and do not reach the many men living in rural areas.

Many of the activists argued that a majority of the funding their organizations receives for HIV-related programs cannot be used for human rights or security advocacy. Conversely, rights-focused funding usually does not allow for provision of HIV prevention and treatment services. They noted that this has greatly increased the division of rights and HIV.  They agreed that it is important for both rights and HIV to be linked as one. Funding for HIV needs to include security and human rights advocacy and also, most importantly, there shouldn’t be a division of rights advocates and HIV advocates as we are all promoters for the good of our communities.   

The need for inclusion of transgender HIV programming in Africa was raised. The representative from a transgender advocacy organization stated that they are left behind in service provision and research. Little to nothing is known about HIV transmission among trans communities in Africa. What is known, however, is that transgender women are 49 times (yes, 49!) more likely to have HIV compared to their general population counterparts. They asked for specific attention to the trans community in all approaches.

The need for research on gay men living with HIV in Africa was raised by an MSM group. Little to nothing is known about this population except that their HIV risks are 19 times higher than those in the general population. The double stigma has limited many of them from accessing health care services. One culprit they cite is the lack of engagement by the national and international communities of people living with HIV.

Many of the delegates were specifically concerned about the new Global Fund and PEPFAR funding models. They agreed there are new opportunities but there are also many challenges around national governments implementing HIV services for gay and transgender communities in the context of criminalization of these very communities. There is need for proper monitoring by Global Fund and PEPFAR to ensure money earmarked for LGBT HIV services is actually funding such programs.  This will be a tall order as delegates emphasized the lack of meaningful engagement from their national governments. This support is key to ensuring seamless and quality services for key populations.

Many of the LGBT delegates’ concerns are not different from what many activists from Africa have been asking for in the last decade:  Meaningful engagement by national governments and international agencies; LGBT adolescent research and programing; specific transgender programs that do not count them as MSM; unified funding that addresses both rights and HIV; and research on HIV among lesbians in Africa.

As an advocate who has been involved in HIV and rights advocacy in Africa for many years, I have experienced and witnessed heightened HIV vulnerability among LGBTs in all its ugly manifestations.  Only when we activists succeed in uniting our struggle for sexual minorities with access to HIV treatment and prevention will we succeed in either. 

Post-2015 Millennium Development Goals affirm a future free of AIDS—but is this enough?

Three days after World AIDS Day, UN Secretary General Ban Ki-moon released the report Road to Dignity by 2030: Ending Poverty, Transforming All Lives and Protecting the Planet. This Synthesis Report aims to provide a roadmap beyond 2015, when the 2000 Millennium Development Goals (MDGs) expire. Among the MDGs is the reversal of the spread of HIV and the achievement of universal access to antiretroviral treatment (ART) for all in need. The MDGs are widely considered to have accelerated the changes in the global epidemic since 2000: Over the last fifteen years, global access to ART increased to an estimated 13 million people and there was a 38 percent reduction in new HIV infections. The MDGs were the backdrop for the “3 by 5” initiative, launched by UNAIDS and WHO in 2003 to provide three million people with ART by the end of 2005.

So what is next? The Synthesis Report addresses the unfinished business of the MDGs as well as new health priorities and challenges, including non-communicable diseases and neglected tropical diseases, and universal coverage and equitable access to health care. The report clearly states this new agenda must “…realize the vision of a future free of AIDS…” This goal, however laudable, is the only reference to future work on HIV/AIDS in all of the report’s almost 50 pages.

Should HIV advocates be concerned about the lack of specific HIV goals? Is this retrenchment—a move away from the previous global commitment? Even if it isn’t, will it be perceived as such by governments or civil society? The short answer: probably not. The AIDS advocacy and activist movement(s) do not need to spend time concerned about lack of detail in the post-MDG goals. There are other frameworks, such as the UNAIDS “90-90-90” campaign, that stakeholders need to put into action to achieve the end of the AIDS epidemic by 2030. Within this work, there’s a need to guarantee that ART reaches everyone who needs it—particularly, women, sex workers, men who have sex with men, transgender people, injection drug users and prisoners. And we need to be sure that care and treatment services and medications are high quality, leading to virologic suppression. That’s a hefty task that will only be achieved with concerted, re-invigorated partnership between civil society, policy makers and program implementers—a level of collective strategizing and collaboration that we haven’t seen before. That’s where the real work is needed.

Worrying about the post-2015 MDG agenda could overstate the role they played in the progress we, the global HIV community, have made, which likely also came from leadership, advocacy and trends independent of the MDGs. The rapid reduction in the price of antiretroviral drugs was key to expanded treatment access. Changes in political leadership were also critical in places such as South Africa. Some bilateral programs such as PEPFAR were not MDG driven. Finally the domestic health response has escalated with low- and middle-income countries investing US$ 9.65 billion in 2013.

The new post-2015 development goals laid out in the UN’s Synthesis Report do not deprive the HIV/AIDS field of a rallying call. Three years ago, people already began talking about ending AIDS—a goal beyond the imagination of the MDG architects. The call to end AIDS, UNAIDS’ 2014 90/90/90 target, and now realizing ” …the vision of a future free of AIDS …” in the Synthesis Report, should carry us forward to 2030.